
ORENCIA
ABATACEPT
- 规格
- 125mg/250mg
- 制造商
- BRISTOL-MYERS SQUIBB Pharma
- 供应情况
- 可供采购
ABATACEPT 125mg/250mg — Injection, 1's Vial

扫码添加微信
药品简介
Originator: ORENCIA by Bristol-Myers Squibb Company. · Manufacturer: BRISTOL-MYERS SQUIBB Pharma. Indication & Dosage: ORENCIA (ABATACEPT), is a prescription medication used to treat of autoimmune diseases such as moderate to severe rheumatoid arthritis, psoriatic arthritis, and polyarticular juvenile idiopathic arthritis. It works by selectively modulating the immune response through inhibition of T-cell activation, thereby reducing inflammation, joint damage, and other symptoms associated with these chronic inflammatory conditions. ORENCIA Manufactured by BRISTOL MYERS SQUIBB Pharma Ltd. in USA. Abatacept is administered by a healthcare professional as an intravenous infusion over approximately 30 minutes, initially at weeks 0, 2, and 4, followed by maintenance doses every 4 weeks thereafter. Side Effects: The most common adverse reactions are: Headache, nausea, cough, dizziness, and mild injection site reactions such as redness, itching, or pain. The above information comes from the Internet. Please consult with doctor for medical advice.
适应症
本信息仅供参考,不构成医疗建议。请务必咨询合格的医疗专业人士。



